Nasdaq: TRAX
First Tracks Biotherapeutics insiders
The officers, directors and 10% owners of First Tracks Biotherapeutics, Inc. who hold the most stock, valued at the live TRAX price.
$44.46
TRAX today −$40K (−0.09%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 2
- Their TRAX stock
- $7.7M
- Market value
- $1.87B
- Held by ranked insiders
- 0.41%
Insiders by value of TRAX holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Daniel Faga | President, CEO | 136,000 | $6.0M | 0.32% | 2929th |
| 2 | John P. Schmid | Director | 37,652 | $1.7M | <0.1% | 11065th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for First Tracks Biotherapeutics; see each profile for the filing.